Joint

Joint EV/EBIT

The EV/EBIT (Enterprise Value to EBIT) of Joint (JYNT) as of Oct 30, 2026 is -127.35. In the previous year, EV/EBIT (Enterprise Value to EBIT) was -61.04 — a change of 108.62% (lower).

EV/EBIT

-127.35

YoY

108.62%

Last updated:

EV/EBIT (Enterprise Value to EBIT) of Joint is 2025 -127.35 . EV/EBIT (Enterprise Value to EBIT) of Joint was 2024 -61.04 . It decreases by 108.62% lower compared to the previous year.

The Joint EV/EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/EBIT
Date
EV/EBIT
Jan 1, 2019
33.77 USD
Jan 1, 2020
21.00 USD
Jan 1, 2021
18.82 USD
Jan 1, 2022
139.23 USD
Jan 1, 2023
362.28 USD
Jan 1, 2024
-61.04 USD
Jan 1, 2025
-127.35 USD
Jan 1, 2026 (e)
22.82 USD
The Joint EV/EBIT history
YEAREV/EBITYoY
est22.82-117.92%
-127.35+108.62%
-61.04-116.85%
362.28+160.21%
139.23+639.62%
18.82-10.35%
21.00-37.83%
33.77-93.99%
562.20-1,647.87%
-36.32+373.17%
-7.68-37.98%
-12.38-82.54%
-70.89—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Joint Valuation

Details

Historical Valuation Multiples

ⓘ

Price-to-Earnings Ratio (P/E)

The P/E ratio divides Joint's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates Joint's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots Joint's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if Joint grows earnings faster than its peers.

Joint Stock analysis

What does Joint do? The Joint Corp is an American company specializing in providing medical and wellness services. It was founded in 2010 and is headquartered in Scottsdale, Arizona. The company currently operates over 600 clinics in the United States and is listed on NASDAQ under the ticker symbol JYNT. Its business model focuses on treating patients with joint and muscle pain through a chain of clinics that specialize in chiropractic, physical therapy, and other wellness-based treatments. The company's main strategy for expansion is through franchise systems, providing support to franchisees in areas such as location selection, building lease, and financing. Joint clinics offer a range of products and services, including chiropractic treatments, physical therapy, sports medicine, acupuncture, supplements, and pain medication. The company has recently partnered with a franchise company in Canada to open clinics in multiple Canadian cities and plans to open clinics in other countries in the coming years. While The Joint brand is known for its affordable wellness concept, it has faced mixed reception from the chiropractic industry due to concerns about quality and patient safety. However, the company has taken steps to address these concerns by hiring qualified chiropractors and physicians and implementing strict quality controls. Overall, The Joint Corp is focused on becoming a leading wellness company in the USA and worldwide, aiming to expand and offer innovative ways to improve patient well-being. Joint is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Joint stock

EV/EBIT (Enterprise Value to EBIT) of Joint is -127.35 in 2025.

EV/EBIT (Enterprise Value to EBIT) of Joint changed from -61.04 to -127.35, representing a 108.62% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/EBIT (Enterprise Value to EBIT) Joint since 2006 – with annual values, charts, and detailed analysis.

The EV/EBIT ratio measures a company's enterprise value relative to its operating earnings. It accounts for debt, making it useful for comparing companies with different capital structures.

EV/EBIT = Enterprise Value / Earnings Before Interest and Taxes

To evaluate EV/EBIT (Enterprise Value to EBIT)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBIT (Enterprise Value to EBIT).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBIT (Enterprise Value to EBIT)'s Joint with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Joint

All Key Metrics — Joint